Objective Liver transplantation is the gold standard approach for decompensated liver
cirrhosis. In recent years, stem cell therapy has raised hopes that adjusting some clinical
and laboratory parameters could lead to successful treatments for this disease. Cirrhotic
patients may have multiple systemic abnormalities in peripheral blood and irregular cell
populations in bone marrow (BM). Correcting these abnormalities before BM aspiration may
improve the effectiveness of cell-based therapy of liver cirrhosis. Materials and Methods In …